Condition

Binge Drinking

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 6 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials6

Recruiting0

Common interventions18

Lead sponsors shown4

Clinical trials

6 shown

Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCVNCT03652675 · 2018-11-01

COMPLETED

Individual and Contextual Factors That Influence Sexual DecisionsNCT03224416 · 2017-05-01

UNKNOWN

Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)NCT02330419 · 2015-04-01

COMPLETED

A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya InterventionNCT01503255 · 2012-07-01

COMPLETED

Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected WomenNCT01125371 · 2011-10-01

COMPLETED

Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected KenyansNCT00792519 · 2009-02-01

COMPLETED

Common interventions

Alcohol AdministrationOTHER1 Attention ControlBEHAVIORAL1 Behavioral survey measurements:BEHAVIORAL1 CBTBEHAVIORAL1 cognitive behavioral group therapyBEHAVIORAL1 Computerized brief alcohol interventionBEHAVIORAL1 Computerized brief alcohol intervention + IVR booster callsBEHAVIORAL1 Dried Blood Spot (DSB) Testing for PhosphatidylethanolDIAGNOSTIC_TEST1 Ecological Momentary AssessmentBEHAVIORAL1 health education groupBEHAVIORAL1 HIV support groupBEHAVIORAL1 Intervention: (Clinician's Guide + HealthCall for HIV/HCV)BEHAVIORAL1 Medical Management (MM) counseling for alcohol use:BEHAVIORAL1 NaltrexoneDRUG1 No Alcohol AdministrationOTHER1 PlaceboDRUG1 Placebo Alcohol AdministrationOTHER1 Urinalysis for novel alcohol biochemical markers:DIAGNOSTIC_TEST1

Leading sponsors

Brown University 3 Johns Hopkins University 1 New York State Psychiatric Institute 1 University of California, San Francisco 1

Trial status mix

COMPLETED5

UNKNOWN1

Phase mix

NA3

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.